Abstract-Herein we report on the synthesis of new ionic compounds based on N-ethoxyethylpiperidine, trimecaine and piromecaine, obtained via N-alkylation with alkyl halides. The combination of piperidine ring, secondary amine group, trimecaine and piromecaine in form of a base with different alkyl radicals bring to molecule new biological activity and/or reduce toxic effects of parent compounds. The potential pharmacological activity and potential toxic effects of the obtained compounds were predicted with PASS online service (Prediction of Activity Spectra for Substances) showing cardiotonic, antiarrhythmic and spasmolytic potential activities. The dependence of the potential activity on the nature of substituent was compared. These novel ionic compounds can be applied for synthesis of ionic compounds and drug candidates.
I. INTRODUCTION
One of the main strategies of the search for new biologically active compounds in the last decade is a combination of two or more pharmacophore groups in one compound [1] . In this manusctipt we are now taking this strategy to a relatively new class of organic compounds -ionic liquids. One well-known example of a successful transition from the molecular (non-ionic) form of the drug to the ionic liquid form is lidocaine docusate [2] -an ionic form of lidocaine is better absorbed by the organism and has a combination of analgesic and emollient properties. The presence of piperidine ring and/or secondary amide group appears to be very interesting in terms of the search for new biologically active compounds [3] - [5] . Especially it worth mentioning the piperidine derivatives those include the general structural part N-ethoxyethylpiperidine, where the ethoxyethyl substituent plays an important role in the occurrence of biological activity [6] . N-ethoxyethylpiperidine derivative: 1-(2-ethoxyethyl)-4-ethynyl-4-benzoyloxy-piperidine . hydroc hloride known as kazcaine shows anesthetic and Tole-bi street, Almaty, 050000, Kazakhstan (e-mail: zolotareva.2909@mail.ru, anna.basharimova@mail.ru, bayazitsarah@gmail.com, azazybin@yahoo.com).
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anti-arrhythmic activity with no teratogenic, embriotoxic, mutagenic and allergic effects [7] . Trimecaine which we used in our research as a parent compound nowadays has been applied as a local anesthetic and antiarrhythmic and in cardio surgery [8] , [9] . Piromecaine also shows local anesthetic and antiarrhythmic activity [10] , [11] . To define the range of biological activity of new synthesized compounds we used Pass online service (Prediction of Activity Spectra for Substances) [12] , which helps to predict biological and pharmacological effects, action mechanisms and also toxicity and adverse impact of compound, for example as in [13] - [15] . In this manuscript we report some methods for the synthesis of new ionic compounds and study of their potential biological activity.
II. SYNTHESIS OF THE IONIC COMPOUNDS BASED ON N-ETHOXYETHYLPIPERIDINE
The acetylene alcohol compound 1-(2-ethoxyethyl)-4-ethynylpiperidin-4-ol was chosen as a starting compound for the synthesis of new ionic substancesdrug candidates. 1-(2-ethoxyethyl)-4-ethynylpiperidin-4-ol was synthesized as hydrochloride by the Favorskii reaction from 1-(2-ethoxyethyl)-4-piperidone according to the well-known procedure [16] . For the purpose of new ionic compounds synthesis it was transferred into the form of a base and then undergone the process of alkylation with alkyl halides.
The general procedure for the alkylation is a treating of 1-(2-ethoxyethyl)-4-ethynylpiperidin-4-ol with acetonitrile solution of corresponding alkyl halide. The mixture is taken under reflux for 0.5 -12 hours. Then the obtained compound is purified with different methods.
At first the ionic compound based on 1-(2-ethoxyethyl)-4-acetyl-4-hydroxypiperidine and methyl iodide -1-(2-ethoxyethyl) -4-ethynyl-4-hydroxy-1-methylpiperidine iodide was synthesized (1) (Fig. 1) . Synthesis was carried out in acetonitrile medium under the reflux for 1 hour. Purification of the product was carried out by crystallization from acetone. In the IR spectrum of the product the shift of vibration bands (cm -1 ) of the functional groups in comparison to the starting material was observed: 3266 (O-H); 2109 (CC), 1276, 1192, 1173 (C-O), 859 (C-N) for the product (1) and 3238 (O-H); 2097 (CC), 1288, 1257, 1226
The mass spectrum of the alkylation product was recorded and the signal with mass 212.2, corresponding the cationic part of 1-(2-ethoxyethyl) -4-ethynyl-4-hydroxy-1-methyl-piperidinium iodide (1) was detected.
For the synthesis of ionic compound with ethyl moiety at the nitrogen atom 1-(2-ethoxyethyl)-4-ethynylpiperidin-4-ol was reacted with ethyl iodide (Fig. 2) . The reaction was performed for 3.5 hours under the reflux in acetonitrile medium to get product (2). In the mass spectrum of the alkylation product the signal with mass 226.2 was detected, corresponding to the cationic part of 1-(2-ethoxyethyl) -4-ethynyl-4-hydroxy-1-ethyl-piperidinium iodide (2) .
In the proton spectrum of the sample the peaks of the methyl groups are observed at 1. 17 Trimecaine and piromecaine are widely used drugs having local anesthetic and antiarrhythmic activity [17] find application in ophthalmology and otolaryngology, for anesthesia in endoscopic studies; intravenously appointed at gastric arrhythmia, at cardiac glycoside intoxication, at acute myocardial infarct [18] . At the same time, ionic compounds based on them are not well studied, especially in terms of their pharmacological activity. In this section, we report on the synthesis of ionic compounds based on trimecaine and piromecaine and study of their physical and chemical characteristics.
In both cases, the pharmaceutical substance was taken in the hydrochloride form. Trimecaine represents the hydrochloride of 2,4,6-trimetilanilide of N,N-diethylamine-acetic acid and piromecaine represents the hydrochloride of 2,4,6-trimethylanilide-1-butyl-pyrrolidine-2-carboxylic acid. Structures are shown in Fig. 3 . To carry out the alkylation reaction trimecaine hydrochloride was transferred into the form of a base by reaction with potassium carbonate, the product was isolated from the aqueous solution by extraction with benzene. Firstly we synthesized (Fig.  4 ) N, N-diethyl-2-(mesitylamino)-N-methyl-oxoethanaminium iodide (3) by alkylation of trimecaine with methyl iodide. After mixing of acetonitrile solutions of reagents the reaction mixture was left at room temperature for 24 hours. Then the solution was heated to reflux and thereafter was concentrated twice. The obtained upon cooling white crystals were crystallized from acetone:hexane 13:1 mixture. The purified product was characterized by IR, NMR spectroscopy. In the IR spectrum a characteristic absorption band of the amide group is observed.
In the 1 H NMR spectrum the protons of methyl groups resonate at 1.28, 2.08, 2.19 and 3.15 ppm. Methylene provides peaks at 3.52 and 4.27 ppm. Peak with chemical shift of 6.87 ppm corresponds to protons of benzene ring. The high-frequency peak at 9.81 ppm can be attributed to a proton of an amide group.
In the carbon spectrum the signals of the methyl groups are found at 8.37-48.46 ppm. Methylene carbons resonates at 57.94 and 59.05 ppm. Low-intensity peaks at 129.02-136.78 ppm refer to the carbon atoms of the benzene ring. The atom of the carbonyl group gives a peak at 162.52 ppm. Here and for the further compounds mentioned in this paper the assignment of the signals was carried out with the involvement of the two-dimensional COSY spectroscopy and
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HMQC.
After working out the methodology of alkylation of trimecaine with methyl iodide, we moved to a more complex and interesting (in terms of potential pharmacological activity) reagent methoxyethoxyethyl bromide (Fig. 5) . Introduction of methoxyethoxyethyl group to the nitrogen atom of the amino group impacts, for example, in the case of ambenoxane [19] , muscle relaxant. It was expected that the long-chain alkyl bromide would be less active than methyl iodide, so the reaction time was increased to 3.5 hours. The solvent was evaporated and the product was dried under vacuum.
The product was characterized by NMR spectroscopy. In the proton spectrum the peaks of the methyl groups of the alkyl substituents are observed at 1.10-3.38 ppm. Peaks at 3.45-3.81 ppm belong to protons of methylene groups at the nitrogen and oxygen heteroatoms. Peak with chemical shift of 6.88 ppm can be attributed to equivalent protons of the aromatic ring, the most lowfield signal (10.28 ppm) corresponds to the proton of the amide group.
In the carbon spectrum most highfield signals at a frequency of 8 Piromecaine is less studied in terms of the biological activity local anesthetic. In the form of a base it is also attractive for the synthesis of ionic compounds. For alkylation reaction commercially available form -piromecaine hydrochloride -was transferred to the form of a base by reaction with potassium carbonate, the product was isolated from the aqueous solution by extraction with benzene. We have carried out the alkylation of piromecaine with methyl iodide (Fig. 6) . The reaction was carried out at 50 °C in acetonitrile medium with the following evaporation of the solvent and crystallization of the product from the mixture of THF and hexane. The product was characterized by NMR spectroscopy. In the proton spectrum the peaks of the methyl and methylene groups of N-butyl radical observed at 0.89-1.64 and 3.65 ppm. The peaks at 1.85, 2.26-2.42 and 3.69 ppm belong to protons of the five-membered heterocyclic ring. Methyl substituents of the aromatic ring resonate at 2.16-2.24 ppm. The peak at 6.86 ppm can be attributed to the protons of the aromatic ring. The most high-frequency peak (9.59 ppm) corresponds to the proton of the amide group.
In the carbon spectrum most highfield (13. Further piromecaine was alkylated with ethyl iodide (Fig.  7) . Interestingly that in contrast to the alkylation with methyl iodide, this reaction does not proceed at a temperature of 50°C in acetonitrile medium. We needed a change of solvent to toluene to carry out the reaction at 110 0 C. The product is obtained in the form of insoluble in toluene white precipitation and separated from the reaction mixture by filtration. The product was characterized by NMR spectroscopy. The signals of the methyl and methylene groups of N-butyl radical observed at 0.88-1.41, 1.70 and 3.73 ppm, while N-ethyl fragment protons resonate at 1.50 (CH 3 ) and 3.37 ppm (CH 2 ). The peaks at 1.83, 2.27-3.29 and 3.95 ppm belong to the protons of the five-membered heterocyclic ring. Methyl substituents of the aromatic rings resonate at 2.15-2.23 ppm. The peak at 6.84 ppm can be attributed to the protons of the aromatic ring. The most high-frequency peak (9.75 ppm) corresponds to the proton of the amide group.
In the carbon spectrum most highfield (9. on its structural formula, using a unified description of the chemical structure and the establishment of a universal mathematical algorithm of "structure-activity" relationship. The program predicts 783 kinds of biological activity by the structural formula of chemical substances, including the main and side pharmacological effects, mechanisms of action, mutagenicity, carcinogenicity, teratogenicity and embryotoxicity [19] .
PASS is based on the analysis of the "structure-activity" relationship for substances from the reference selection, containing over 45000 different biologically active substances (known drugs and pharmacologically active compounds). The reference selection is constantly updated with new information on biologically active substances, which are selected from scientific publications as well as from numerous databases [20] .
Herein (Table I) we report a PASS prediction of potential biological activity and potential toxic effects for the reported here N-ethoxyethylpiperidine, trimecaine and piromecaine derivatives, where percentage corresponds to the probability of the effect. As it is seen from the Table I , N-ethoxyethylpiperidine derivatives (compounds (1) and (2)) showed spasmolytic, ovulation inhibition and progestin antagonist potential activity, from the other hand these two compounds showed possible teratogen and embryotoxic effects. Trimecaine derevatives (3) and (4) showed cardiotonic, spasmolytic and calcium channel activator effects with twitching, apnea and euphoria possible toxic effects. Piromecaine derivatives (5) and (6) showed gastrin inhibitor, membrane integrity antagonist and general pump inhibitor potential activity, as well as twitching, euphoria and sneezing possible toxic effects. Anesthetic local * the numbers of compounds correspond to those mentioned in this paper The next step of our research is a comparison of potential activities between two obtained compounds depending on the nature of a substituent. First, two compounds (1) and (2), which differs only in the nature of a substituent at nitrogen atom (CH 3 or C 2 H 5 ) were compared. It can be observed that generally the potential biological activity of the compound (2) is higher which may correspond to the more strong inductive effect of the ethyl group (Fig. 8) . (1) and (2).
On the next charts ( Fig. 9 and 10 ) the similar situation with
changing of potential biological activity depending on the nature of a substituent at nitrogen atom for compounds (3) , (4) and (5), (6) , correspondingly, is observed. Fig. 9 . Comparison of potential activities of compounds (3) and (4). (5) and (6). V. EXPERIMENTAL PART IR spectra were recorded on a spectrometer « Nicolet 5700 FT-IR» in the thin film. )  -4-ethynyl-4-hydroxy-1-methylpiperidine iodide (1) 2.15 g (0.01 mol) of 1-(2-ethoxyethyl) -4-acetyl-4-hydroxypiperidine was dissolved in 40 ml of acetonitrile and a solution of 0.705 ml (0.011 mol) of methyl iodide in 5 ml acetonitrile was added. The solution was kept under reflux for 1 h, thereafter acetonitrile was removed by evaporation.
1-(2-Ethoxyethyl
2 ). Trimecaine 2.054 g (0.00703 mol) of trimecaine hydrochloride was dissolved in 15 ml of water. The solution had pH = 6.5. K 2 CO 3 was added until pH = 8-9. Extraction was performed three times with benzene (15 ml). The resulting extract was dried with anhydrous calcium chloride for 8 hours. The solvent was removed by simple distillation. The product was dried for two hours in vacuum at 70°C. Yield of trimecaine is 1.492 g (85.57 %). 13 Applications, Vol. 8, No. 3, June 2017 N,N-Diethyl-2-(mesitylamino)-N-methyl-oxoethanamin  ium iodide (3) 1.492 g (0.006 mol) of trimecain were dissolved in 5 ml of acetonitrile. 0.41 ml (0.007 mol) of methyl iodide were dissolved in 5 ml of acetonitrile. After mixing together the resulting solution was left for 24 hrs. Then the volume of the solution was reduced 2-3 times with evaporation. After cooling white crystals were formed. (2.148 g). Purification was performed by crystallization from acetone: hexane (13: 
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N,N-Diethyl-2-mesitylamino-N-(-2-(2-methoxyethoxy) ethyl) -2-oxo-ethaneammonium bromide (4)
2.056 g (0.008 mol) of trimecaine were dissolved in 20 ml of acetonitrile. This solution was added to 1.6 ml (0.009 mol) of methoxyethoxyethyl bromide. The resulting solution was heated to reflux for 3.5 hours. The solvent was removed by evaporation. The yellow viscous mass was obtained. The yield was not determined, for further studies it was used without further purification. 
1-Butyl -2-(mesitylcarbamoyl) -1-ethyl-pyrrolidinium-1 iodide (6)
3.715 g (0.0129 mol) of piromecain were dissolved in 40 ml of acetonitrile. 2.28 ml (0.0284 mol) of ethyl iodide were dissolved in 5 ml of acetonitrile. Two solutions were mixed together and were heated for 30 minutes at 50°C. After the solvent was distilled off the sand-colored viscous wax-like substance was obtained (3.858 g). It was dissolved in 25 ml of toluene and refluxed for 11 hours. After cooling to 4 0 C the crystals (white slurry) were precipitated and then filtered off. The product was dried under vacuum for 40 minutes. Yield 0.447 g (7.8%). M.p. 193-196°С. 13 have been synthesized. Optimal conditions for the reactions were found. The prediction of potential biological activity was carried out using PASS online service. Through this service not only potential biological and pharmacological activity, but also potential toxic effects and compared change of activities between similar compounds with different carbon radicals was determined. The results will be used in the field of synthesis of new ionic compounds and new drug candidates.
